Clinical Trials Insight: 700028189
Phase of Trial: Phase I/II
Latest Information Update: 24 Jul 2008
At a glance
- Drugs Cixutumumab (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors ImClone Systems
- 24 Jul 2008 Status changed from planned to recruiting as reported by ImClone Systems.
- 06 Nov 2007 New trial record.